Fibroblast interferon treatment of a patient with chronic active hepatitis
- 1 July 1979
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 67 (1) , 127-131
- https://doi.org/10.1016/0002-9343(79)90088-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.Gut, 1978
- Immune Mechanisms and the Action of Interferon in Chronic Hepatitis B Virus InfectionImmunological Communications, 1978
- T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infectionGut, 1977
- Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis.Journal of Clinical Investigation, 1977
- Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active HepatitisNew England Journal of Medicine, 1976
- ADMINISTRATION OF HUMAN FIBROBLAST INTERFERON IN CHRONIC HEPATITIS-B INFECTIONThe Lancet, 1976
- T Cells and B Cells in HBsAg-Positive Patients with Chronic Persistent Hepatitis and Asymptomatic CarriersAnnals of Internal Medicine, 1976
- Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interactionBiochemistry, 1976
- Hepatitis B surface antigen and liver cell carcinomaThe Lancet Healthy Longevity, 1975
- T CELLS, B CELLS, AND HL-A8 IN CHRONIC ACTIVE HEPATITISThe Lancet, 1975